tiprankstipranks
Alnylam Pharmaceuticals (DE:DUL)
XETRA:DUL
Germany Market
DUL
Alnylam Pharma
RESEARCH TOOLSreports

Alnylam Pharma (DUL) Ratios

4 Followers

Alnylam Pharma Ratios

DE:DUL's free cash flow for Q2 2026 was $0.77. For the 2026 fiscal year, DE:DUL's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.05 2.76 2.78 3.08 3.51
Quick Ratio
 2.99 2.71 2.71 2.99 3.34
Cash Ratio
 1.13 1.13 0.81 0.84 1.13
Solvency Ratio
 0.21 0.09 -0.05 -0.10 -0.29
Operating Cash Flow Ratio
 0.42 0.36 >-0.01 0.11 -0.70
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.07 0.00 0.00
Net Current Asset Value
$ 415.52M$ -126.49M$ -877.61M$ -1.07B$ -1.01B
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.26 0.65 0.34 0.37
Debt-to-Equity Ratio
 0.94 1.62 40.89 -5.92 -8.34
Debt-to-Capital Ratio
 0.48 0.62 0.98 1.20 1.14
Long-Term Debt-to-Capital Ratio
 0.43 0.56 0.97 1.28 1.18
Financial Leverage Ratio
 4.11 6.29 63.20 -17.36 -22.41
Debt Service Coverage Ratio
 3.66 2.46 -0.31 -2.19 -5.97
Interest Coverage Ratio
 3.08 1.99 -1.25 -2.33 -5.03
Debt to Market Cap
 0.03 0.02 0.08 0.04 0.04
Interest Debt Per Share
 11.95 11.69 22.60 11.42 12.13
Net Debt to EBITDA
 -0.38 -0.60 -9.94 -1.91 -0.49
Profitability Margins
Gross Profit Margin
79.72%81.77%85.62%83.02%83.73%
EBIT Margin
22.81%15.50%-10.48%-17.08%-93.60%
EBITDA Margin
23.95%17.00%-7.95%-14.12%-89.31%
Operating Profit Margin
20.81%13.51%-7.87%-15.43%-75.68%
Pretax Profit Margin
16.64%8.70%-16.79%-23.71%-108.63%
Net Profit Margin
16.82%8.45%-12.37%-24.08%-109.04%
Continuous Operations Profit Margin
17.47%8.45%-12.37%-24.08%-109.04%
Net Income Per EBT
101.05%97.09%73.71%101.55%100.37%
EBT Per EBIT
79.97%64.43%213.34%153.63%143.55%
Return on Assets (ROA)
14.54%6.32%-6.56%-11.49%-31.90%
Return on Equity (ROE)
93.61%39.76%-414.62%199.53%714.91%
Return on Capital Employed (ROCE)
24.71%14.33%-5.79%-9.86%-28.26%
Return on Invested Capital (ROIC)
24.43%13.74%-4.06%-9.72%-27.84%
Return on Tangible Assets
14.54%6.32%-6.56%-11.49%-31.90%
Earnings Yield
2.35%0.60%-0.93%-1.84%-3.91%
Efficiency Ratios
Receivables Turnover
 5.26 4.78 5.55 5.58 4.36
Payables Turnover
 9.02 5.85 3.66 5.59 1.72
Inventory Turnover
 10.03 8.19 4.12 3.48 1.31
Fixed Asset Turnover
 6.51 5.25 3.24 2.52 1.40
Asset Turnover
 0.86 0.75 0.53 0.48 0.29
Working Capital Turnover Ratio
 1.61 1.58 1.09 0.93 0.51
Cash Conversion Cycle
 65.26 58.63 54.62 104.98 150.46
Days of Sales Outstanding
 69.35 76.42 65.80 65.44 83.72
Days of Inventory Outstanding
 36.38 44.59 88.62 104.82 278.83
Days of Payables Outstanding
 40.46 62.37 99.80 65.28 212.09
Operating Cycle
 105.72 121.00 154.42 170.26 362.55
Cash Flow Ratios
Operating Cash Flow Per Share
 4.76 4.00 -0.07 0.83 -4.45
Free Cash Flow Per Share
 4.07 3.55 -0.33 0.34 -5.04
CapEx Per Share
 0.69 0.45 0.27 0.50 0.59
Free Cash Flow to Operating Cash Flow
 0.86 0.89 5.12 0.40 1.13
Dividend Paid and CapEx Coverage Ratio
 6.90 8.93 -0.24 1.67 -7.51
Capital Expenditure Coverage Ratio
 6.90 8.93 -0.24 1.67 -7.51
Operating Cash Flow Coverage Ratio
 0.50 0.41 >-0.01 0.08 -0.41
Operating Cash Flow to Sales Ratio
 0.13 0.14 >-0.01 0.06 -0.52
Free Cash Flow Yield
1.57%0.89%-0.14%0.18%-2.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 42.30 166.38 -107.99 -54.31 -25.57
Price-to-Sales (P/S) Ratio
 7.19 14.03 13.36 13.08 27.88
Price-to-Book (P/B) Ratio
 25.39 66.01 447.73 -108.36 -182.78
Price-to-Free Cash Flow (P/FCF) Ratio
 63.63 111.94 -705.29 569.99 -47.15
Price-to-Operating Cash Flow Ratio
 54.18 99.40 -3.61K 229.54 -53.43
Price-to-Earnings Growth (PEG) Ratio
 0.01 -0.79 2.84 0.87 -0.88
Price-to-Fair Value
 25.39 66.01 447.73 -108.36 -182.78
Enterprise Value Multiple
 29.63 81.90 -177.89 -94.49 -31.70
Enterprise Value
 34.08B 51.71B 31.81B 24.40B 29.37B
EV to EBITDA
 29.63 81.90 -177.89 -94.49 -31.70
EV to Sales
 7.09 13.92 14.15 13.35 28.31
EV to Free Cash Flow
 62.82 111.12 -747.01 581.74 -47.89
EV to Operating Cash Flow
 53.72 98.68 -3.83K 234.27 -54.27
Tangible Book Value Per Share
 10.16 6.02 0.53 -1.77 -1.30
Shareholders’ Equity Per Share
 10.16 6.02 0.53 -1.77 -1.30
Tax and Other Ratios
Effective Tax Rate
 -0.05 0.03 0.26 -0.02 >-0.01
Revenue Per Share
 36.06 28.35 17.61 14.64 8.53
Net Income Per Share
 6.06 2.39 -2.18 -3.52 -9.30
Tax Burden
 1.01 0.97 0.74 1.02 1.00
Interest Burden
 0.73 0.56 1.60 1.39 1.16
Research & Development to Revenue
 0.31 0.36 0.50 0.55 0.85
SG&A to Revenue
 0.27 0.33 0.43 0.44 0.74
Stock-Based Compensation to Revenue
 0.07 0.09 0.12 0.12 0.22
Income Quality
 0.79 1.67 0.03 -0.24 0.48
Currency in USD